Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04289818
Other study ID # PS002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2018
Est. completion date March 31, 2020

Study information

Verified date November 2022
Source Indonesia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In Indonesia and others countries, only 30.8% patients with type 2 diabetes mellitus (T2DM) achieved glycemic control with HbA1c <7%. Optimal pharmacological treatment alone does not guarantee an optimal outcome, therefore it should be combined with lifestyle management. Health coaching helps T2DM patients increase self awareness to improve and maintain behavior which play a role in self-management. This study aims to evaluate the impact of health coaching on glycemic control on T2DM patients.


Description:

Subjects randomized into 2 groups: control and intervention group. All subject received education class in top of standard treatment. Intervention group received additional personal health coaching. Education and health coaching was given for 12 sessions every 2 weeks with 12 different themes for each session. Health coaching were given by International certified health coach. Laboratory examination and questionnaire collected at baseline, 3 and 6 months after intervention.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date March 31, 2020
Est. primary completion date August 31, 2018
Accepts healthy volunteers No
Gender All
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - T2DM patients - aged 30-60 years old - HbA1C > 7.5% within the past 3 months - able to write and read. Exclusion Criteria: - Patients with cognitive disease (such as dementia) - having hearing problem or sight problem - unable to live independently on daily basis - having disease that may affect HbA1c result (eg: hemolytic anemia)

Study Design


Intervention

Other:
Health Coaching
Health Coaching as face to face with a coach

Locations

Country Name City State
Indonesia Faculty of Medicine, Universitas Indonesia Jakarta Pusat DKI Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline HbA1c at 3 months Glycemic Control 3 month after intervention
Primary Change from Baseline HbA1c at 6 months Glycemic Control 6 month after intervention
Secondary Change from Baseline Fasting Plasma Glucose at 3 months Glycemic Control 3 month after intervention
Secondary Change from Baseline 2-hours post prandial plasma glucose at 3 months Glycemic control 3 months after intervention
Secondary Change from HDL-cholesterol at 3 months Diabetes mellitus control 3 months after intervention
Secondary Change from LDL-cholesterol at 3 months Diabetes mellitus control 3 months after intervention
Secondary Change from Triglycerides at 3 months diabetes mellitus control 3 months after intervention
Secondary Change from Total Cholesterol at 3 months Diabetes mellitus control 3 months after intervention
Secondary Change of Body mass index at 3 months Diabetes mellitus control 3 month after intervention
Secondary Change calorie intake at 3 months life style parameter 3 month after intervention
Secondary International Physical Activity Questionnaire (IPAQ) questionnaire consist of several question about activities in the whole week. Scoring divided into 3 categories : low, moderate, high. This questionnaire is to describe activities no to divided whether high score means good or bad baseline, 3 month and 6 months after intervention
Secondary EQ-5D quality of life questionnaire This questionnaire consist of several question with 5 main outcome mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Subjects will answer the question with fully, half or none. baseline, 3 month and 6 months after intervention
Secondary Change from Baseline Fasting Plasma Glucose at 6 months Glycemic Control 6 month after intervention
Secondary Change from Baseline 2-hours post prandial plasma glucose at 6 months Glycemic Control 6 months after intervention
Secondary Change from HDL-cholesterol at 6 months diabetes mellitus Control 6 months after intervention
Secondary Change from LDL-cholesterol at 6 months diabetes mellitus Control 6 months after intervention
Secondary Change from Triglycerides at 6 months diabetes mellitus Control 6 months after intervention
Secondary Change from Total Cholesterol at 6 months diabetes mellitus Control 6 months after intervention
Secondary Change from systolic and diastolic blood pressure at 6 months diabetes mellitus Control 6 months after intervention
Secondary Change calorie intake at 6 months life style parameter 6 months after intervention
Secondary Change of Body mass index at 6 months diabetes mellitus control 6 months after intervention
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Active, not recruiting NCT04954313 - Baseline Oral Health Study: UnCoVer the Connections to General Health Phase 4
Not yet recruiting NCT06437782 - Exploration of Health Literacy in Diabetes in Reunion Island and France
Completed NCT01354925 - Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan Phase 4
Completed NCT01206725 - Exercise Study on Cardiac Function in Patients With Diabetes Mellitus Type 2 and Diastolic Dysfunction N/A
Completed NCT00997282 - A Study of OPC-262 in Patients With Type 2 Diabetes Phase 2/Phase 3
Completed NCT00637546 - Gait and Balance of Diabetes Type 2 Patients Phase 2/Phase 3
Completed NCT00464880 - Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy Phase 1/Phase 2
Withdrawn NCT02057497 - An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms N/A
Active, not recruiting NCT05014204 - Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes N/A
Recruiting NCT03662217 - Personalized Nutrition for Diabetes Type 2 N/A
Completed NCT04276051 - Cryovagotomy Diabetes Trial N/A
Completed NCT02569684 - Effects of Prebiotics on GLP-1 in Type 2 Diabetes N/A
Active, not recruiting NCT01933529 - ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) Phase 2
Terminated NCT01722474 - Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness. N/A
Completed NCT00977262 - Postprandial Inflammation and Fatty Acids N/A
Completed NCT00518427 - Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine Phase 4
Recruiting NCT05378620 - Project Dulce for Filipino-Americans With Type 2 Diabetes N/A
Recruiting NCT03834207 - A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy N/A
Active, not recruiting NCT05228067 - Enhancing Brain Health by tDCS in Persons With Overweight and Obesity N/A